APX Ophthalmology

About

APX Ophthalmology has created a safe, easy-to-use pupil dilator and expander that is fast and easy to insert and remove, requires no intraocular manipulations, and does not impede surgical instruments within the surgical field. The scissor-like device is designed to increase efficiency, with blunt, rounded terminal tips on the internal side and a Nitinol spring on the outer side. The device is designed to provide surgeons with effective pupil dilation, comfortable surgical performance, and a high safety profile in eyes with small pupils or floppy iris syndrome.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary product developed by APX Ophthalmology?

APX Ophthalmology has developed a pupil dilator and expander, known as the APX 200, designed for use in ophthalmic surgeries.

When was APX Ophthalmology founded?

APX Ophthalmology was founded in October 2011.

What is the current status of APX Ophthalmology?

APX Ophthalmology is currently inactive, having ceased operations in May 2024.

Where is APX Ophthalmology headquartered?

APX Ophthalmology is headquartered in Haifa, Israel.

What is the estimated employee count for APX Ophthalmology?

APX Ophthalmology has an estimated employee count of 1-10 individuals.

Who are the founders of APX Ophthalmology?

The founders of APX Ophthalmology are Elie Eliachar and Ehud Assia.

Has APX Ophthalmology received any external funding?

According to startupim data, APX Ophthalmology has not reported any total raised USD.

What is a key feature of APX Ophthalmology's pupil dilator and expander?

The device is designed to be safe, easy to insert and remove, requires no intraocular manipulations, and does not impede surgical instruments within the surgical field.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

APX Ophthalmology — Full Company Profile (machine-readable)

Pupil Dilation and Expansion Device

About

Facts

Name	APX Ophthalmology
Slug	apx-ophthalmology
Type	Israeli Startup
Founded	2011
HQ city	Haifa
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Mature
Public stage	Mature
Total raised (USD)	0
Crunchbase ID	apx-ophthomology
Israeli Companies Registrar	514681899

Team (2)

Name	Role	LinkedIn
Elie Eliachar
Ehud Assia

News mentions (4)

May 24, 2018 — crstoday.com: Article
Apr 10, 2017 — www.healio.com: Article
Apr 1, 2016 — crstoday.com: Article
Jul 1, 2013 — www.eyeworld.org: Article

Intelligence Q&A

What is the primary product developed by APX Ophthalmology?

APX Ophthalmology has developed a pupil dilator and expander, known as the APX 200, designed for use in ophthalmic surgeries.

When was APX Ophthalmology founded?

APX Ophthalmology was founded in October 2011.

What is the current status of APX Ophthalmology?

APX Ophthalmology is currently inactive, having ceased operations in May 2024.

Where is APX Ophthalmology headquartered?

APX Ophthalmology is headquartered in Haifa, Israel.

What is the estimated employee count for APX Ophthalmology?

APX Ophthalmology has an estimated employee count of 1-10 individuals.

Who are the founders of APX Ophthalmology?

The founders of APX Ophthalmology are Elie Eliachar and Ehud Assia.

Has APX Ophthalmology received any external funding?

According to startupim data, APX Ophthalmology has not reported any total raised USD.

What is a key feature of APX Ophthalmology's pupil dilator and expander?

The device is designed to be safe, easy to insert and remove, requires no intraocular manipulations, and does not impede surgical instruments within the surgical field.

About

Company Intelligence Q&A

Sectors & technology

Highlights

Tags